KYIV, Ukraine and SALT LAKE CITY, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced ...

Kyiv, Ukraine and Salt Lake City, UT, April 09, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced ...

Innovation in Design, Supply and Acquisition for Compound Screening Libraries, seeks to inform and create a dynamic environment for discussion around this important topic. In this ever evolving area, ...

Metrion Biosciences Limited (“Metrion”), and Enamine Ltd (“Enamine”), announced that Metrion has enhanced its High Throughput Screening (HTS) services with the addition of access to Enamine’s compound ...

In hit finding for chemical probe and drug discovery, a screen is only as good at the molecules that go into it. With the vast potential chemical space, how do you decide what to include in your ...

Horizon Discovery, a global leader in the application of gene editing and gene modulation to deliver inspired cell solutions, announced the introduction of Edit-R™ CRISPRa arrayed crRNA (CRISPR RNA) ...

CAMBRIDGE, England & KYIV, Ukraine--(BUSINESS WIRE)--Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organisation (CRO) and drug ...

Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organization (CRO) and drug discovery company, and Enamine Ltd (“Enamine”), the ...